Akron Biotech

David Smith, Chief Commercial Officer

Oct 13 | 10:45am | BlueRock Therapeutics Ballroom

Boca Raton, FL


In-person Presentation

Akron Biotech drives advanced therapy development and commercialization with high-quality, industrial-scale solutions. Akron’s strategic focus is to work collaboratively with our customers to manufacture cGMP-compliant ancillary materials and provide services that enable the advancement of cell and gene therapies. These include cytokines and growth factors, human sera and purified proteins, cryopreservation solutions, plasmid DNA manufacturing, and custom development services. In addition, our services and capabilities such as raw materials qualification, logistics and packaging optimization, bioassay design, validation, and regulatory services provide our customers with unique knowledge and expertise. As a regulatory compliant company, Akron supports clients with rigorous documentation and quality standards to fulfill their regulatory demands. Our unique capabilities help our customers seamlessly transition from R&D to preclinical and clinical development with minimal change control, driving the emerging regenerative medicine sector to unmet clinical needs through affordable and seamless manufacturing options.

By using this website you agree to accept our Privacy Policy and Terms & Conditions